{"id":3554,"date":"2025-02-18T21:35:27","date_gmt":"2025-02-18T21:35:27","guid":{"rendered":"https:\/\/ihvnigeria.org\/excel-rite\/?page_id=3554"},"modified":"2025-03-03T16:58:48","modified_gmt":"2025-03-03T16:58:48","slug":"richard-adegbola","status":"publish","type":"page","link":"https:\/\/ihvnigeria.org\/excel-rite\/richard-adegbola\/","title":{"rendered":"Richard Adegbola"},"content":{"rendered":"

Richard A. Adegbola <\/b>| MSc PhD, FRCPath, FAS, FAAS, FAMedS<\/span><\/span><\/h3>\n<\/div>
<\/a><\/a><\/a><\/div><\/div><\/div><\/div><\/div>

\nFor over four decades, Prof. Richard Adegbola has leveraged his expertise as a microbiologist
\nand public health advocate to protect vulnerable communities from preventable diseases. He
\ncurrently serves as Chairman of the National Health Research Ethics Committee (NHREC)
\nNigeria, and works as a Research Professor & Consultant at the Nigerian Institute of Medical
\nResearch. His present focus is on strengthening vaccine implementation and enhancing
\nhealthcare system capacity to reduce pneumonia-related deaths among children under fivethe
\nleading cause of death in this age group in Nigeria- despite the availability of effective
\nvaccines. During his tenure at the Medical Research Council (MRC) Unit in The Gambia, part
\nof the London School of Hygiene and Tropical Medicine (LSHTM), Prof. Adegbola played a
\npivotal role in advancing the widespread adoption of the Haemophilus influenzae type b (Hib)
\nconjugate vaccine. Routine use of this vaccine has resulted in a 90% reduction in severe Hib
\ninfections globally. After a distinguished 20-year career with the MRC, he joined the Bill &
\nMelinda Gates Foundation as a Senior Program Officer for pneumonia clinical studies.
\nSubsequently, he served as Global Director of Scientific Affairs and Public Health at
\nGlaxoSmithKline. Prof. Adegbola has received international recognition for his important
\ncontributions to vaccine science and his grassroots efforts to promote immunization
\nawareness across sub-Saharan Africa. <\/p>\n

He holds a PhD in Medical Microbiology and
\nBacteriology from the University of Dundee, UK. His extensive list of publications can be
\naccessed here: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=adegbola+r<\/p>\n<\/div><\/div><\/div>

<\/span><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"content-type":"","footnotes":""},"class_list":["post-3554","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/pages\/3554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/comments?post=3554"}],"version-history":[{"count":5,"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/pages\/3554\/revisions"}],"predecessor-version":[{"id":3701,"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/pages\/3554\/revisions\/3701"}],"wp:attachment":[{"href":"https:\/\/ihvnigeria.org\/excel-rite\/wp-json\/wp\/v2\/media?parent=3554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}